DrugRepV Browse Page


DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Antischistosomal are 6




DrugRepV_ID Antiviral Name
Drug type
Primary Indication
Secondary Indication
Strain
Pathways
Assay
Activity
Clinical Status
 References
DrugRepV_0389Hycanthone
Antischistosomal
Parasitic infections
Ebola virus
eGFP-EBOV
NA
Fluorescence-based assay
Decrease (50 %)
Experimental
26041706
DrugRepV_0434Hycanthone
Antischistosomal
Parasitic infections
Ebola virus
eGFP-EBOV
NA
Fluorescence-based assay
Decrease (50 %)
Experimental
26041706
DrugRepV_0461Hycanthone
Antischistosomal
Parasitic infections
Ebola virus
eGFP-EBOV
NA
Fluorescence-based assay
Decrease (50 %)
Experimental
26041706
DrugRepV_0490Hycanthone
Antischistosomal
Parasitic infections
Ebola virus
EBOV-VLP
NA
Flow cytometry
Decrease (>90 %)
Experimental
26041706
DrugRepV_5771Hycanthone
Antischistosomal
Parasitic infections
Dengue virus
Singapore isolates
Pathway
Plaque assay
Decrease (90 %)
Experimental
25251726
DrugRepV_7676Hycanthone
Antischistosomal
Parasitic infections
SARS Coronavirus-2
NA
Cytopathic effect (CPE) assay
Decrease (50 %)
Experimental
32511355